MedPath

CANCER INTELLIGENCE CARE SYSTEMS, INC.

CANCER INTELLIGENCE CARE SYSTEMS, INC. logo
🇯🇵Japan
Ownership
Subsidiary
Established
2005-12-14
Employees
-
Market Cap
-
Website
http://www.cics.jp

Clinical Trials

4

Active:1
Completed:3

Trial Phases

2 Phases

Phase 1:2
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (66.7%)
Not Applicable
1 (33.3%)

Boron Neutron Capture Therapy Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma

Not Applicable
Completed
Conditions
Angiosarcoma
Malignant Melanoma
First Posted Date
2020-03-03
Last Posted Date
2023-02-08
Lead Sponsor
Cancer Intelligence Care Systems, Inc.
Target Recruit Count
10
Registration Number
NCT04293289
Locations
🇯🇵

National Cancer Center Hospital, Chuo Ku, Tokyo, Japan

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.